BICO Group AB is a bio-convergence company. The company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Group consists of three reporting segments: Bioprinting, Life Science Solutions, and Lab Automation. Bioprinting consists of CELLINK, MatTek, Visikol, and Advanced BioMatrix. Life Science Solutions consists of CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, and Cellenion. Lab Automation consists of Biosero.
2000
726
LTM Revenue $205M
LTM EBITDA $19.7M
$370M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BICO Group has a last 12-month revenue of $205M and a last 12-month EBITDA of $19.7M.
In the most recent fiscal year, BICO Group achieved revenue of $193M and an EBITDA of $50.2M.
BICO Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See BICO Group valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $223M | $193M | XXX | XXX | XXX |
Gross Profit | $182M | $167M | XXX | XXX | XXX |
Gross Margin | 81% | 86% | XXX | XXX | XXX |
EBITDA | $34.3M | $50.2M | XXX | XXX | XXX |
EBITDA Margin | 15% | 26% | XXX | XXX | XXX |
Net Profit | -$82.7M | -$197M | XXX | XXX | XXX |
Net Margin | -37% | -102% | XXX | XXX | XXX |
Net Debt | $46.4M | $61.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, BICO Group's stock price is SEK 36 (or $4).
BICO Group has current market cap of SEK 2.6B (or $254M), and EV of SEK 3.7B (or $370M).
See BICO Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$370M | $254M | XXX | XXX | XXX | XXX | $-0.12 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, BICO Group has market cap of $254M and EV of $370M.
BICO Group's trades at 1.8x LTM EV/Revenue multiple, and 18.8x LTM EBITDA.
Analysts estimate BICO Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for BICO Group and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $370M | XXX | XXX | XXX |
EV/Revenue | 1.9x | XXX | XXX | XXX |
EV/EBITDA | 7.4x | XXX | XXX | XXX |
P/E | -465.3x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 51.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBICO Group's NTM/LTM revenue growth is 4%
BICO Group's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, BICO Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate BICO Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for BICO Group and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -13% | XXX | XXX | XXX | XXX |
EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
EBITDA Growth | 46% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 30% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 28% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 18% | XXX | XXX | XXX | XXX |
Opex to Revenue | 67% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BICO Group acquired XXX companies to date.
Last acquisition by BICO Group was XXXXXXXX, XXXXX XXXXX XXXXXX . BICO Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was BICO Group founded? | BICO Group was founded in 2000. |
Where is BICO Group headquartered? | BICO Group is headquartered in Sweden. |
How many employees does BICO Group have? | As of today, BICO Group has 726 employees. |
Who is the CEO of BICO Group? | BICO Group's CEO is Ms. Maria Forss. |
Is BICO Group publicy listed? | Yes, BICO Group is a public company listed on STO. |
What is the stock symbol of BICO Group? | BICO Group trades under BICO ticker. |
When did BICO Group go public? | BICO Group went public in 2016. |
Who are competitors of BICO Group? | Similar companies to BICO Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of BICO Group? | BICO Group's current market cap is $254M |
What is the current revenue of BICO Group? | BICO Group's last 12-month revenue is $205M. |
What is the current EBITDA of BICO Group? | BICO Group's last 12-month EBITDA is $19.7M. |
What is the current EV/Revenue multiple of BICO Group? | Current revenue multiple of BICO Group is 1.8x. |
What is the current EV/EBITDA multiple of BICO Group? | Current EBITDA multiple of BICO Group is 18.8x. |
What is the current revenue growth of BICO Group? | BICO Group revenue growth between 2023 and 2024 was -13%. |
Is BICO Group profitable? | Yes, BICO Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.